title: Antiserotoninergic activity of 2-aminoethylbenzocyclanones in rat aorta: structure-activity relationships.
abstract: The antiserotoninergic activity at the serotonin receptor subtype 2 (5-HT2) of seven new 2-aminoethylbenzocyclanones was determined with respect to serotonin-induced contractions in rat aorta and compared with that of ketanserine (pA2 = 8.87). Competitive antagonism was observed in six compounds (6.72 < or = pA2 < or = 8.12). Three-dimensional structures and molecular electrostatic potential distributions of ketanserine and 2-aminoethylbenzocyclanones were analyzed. Several molecular features correlated with the rank of antiserotoninergic activity. In the case of the cyclanone fragment, the rank of activity was associated with the degree of planarity of the bicyclic system. The steric and electrostatic effects due to the loss of planarity were analyzed. In the case of the amino moiety, activity was associated with a particular spatial pattern defined by the amino nitrogen, the aromatic system, and molecular electrostatic potential minima generated by the oxygen atom.
authors.affiliation: Department of Pharmacology, University of Santiago, Spain.
authors.forename: M I
authors.initials: MI
authors.lastname: Loza
authors.forename: T G
authors.initials: TG
authors.lastname: Ferreiro
authors.forename: F
authors.initials: F
authors.lastname: Sanz
authors.forename: E
authors.initials: E
authors.lastname: Lozoya
authors.forename: J
authors.initials: J
authors.lastname: Rodriguez
authors.forename: F
authors.initials: F
authors.lastname: Manaut
authors.forename: I
authors.initials: I
authors.lastname: Verde
authors.forename: E
authors.initials: E
authors.lastname: Castro
authors.forename: J A
authors.initials: JA
authors.lastname: Fontenla
authors.forename: I
authors.initials: I
authors.lastname: Cadavid
mesh_terms: D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D002090:Butyrophenones / Q000138:chemical synthesis* / Q000494:pharmacology; D066298:In Vitro Techniques; D007650:Ketanserin / Q000494:pharmacology; D007659:Ketones / Q000138:chemical synthesis* / Q000494:pharmacology; D008968:Molecular Conformation; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D010880:Piperidines / Q000138:chemical synthesis* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists / Q000138:chemical synthesis* / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D002090:Butyrophenones; D007659:Ketones; D010880:Piperidines; D012702:Serotonin Antagonists; D012701:Serotonin; D007650:Ketanserin